TipRanks
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
LEXX
Lexaria Bioscience
RESEARCH TOOLSreports

Lexaria Bioscience (LEXX) Income Statement

249 Followers

Lexaria Bioscience Income Statement

Last quarter (Q3 2026), Lexaria Bioscience's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q3, Lexaria Bioscience's net income was $-1.99M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 25Aug 24Aug 23Aug 22Aug 21
Total Revenue
$ 705.92K$ 464.28K$ 226.21K$ 255.40K$ 722.74K
Gross Profit
$ 703.20K$ 459.46K$ 194.71K$ 183.56K$ 547.39K
Operating Expenses
$ 12.58M$ 6.21M$ 6.73M$ 6.80M$ 6.23M
Depreciation and Amortization
$ 87.83K$ 76.15K$ 145.40K$ 102.72K$ 147.60K
EBITDA
$ -11.82M$ -5.73M$ -6.57M$ -7.28M$ -4.02M
Operating Income
$ -11.88M$ -5.75M$ -6.53M$ -6.62M$ -5.69M
Other Income/Expenses
$ -30.70K$ -55.52K$ -178.50K$ -764.61K$ 1.52M
Pretax Income
$ -11.91M$ -5.81M$ -6.71M$ -7.38M$ -4.16M
Net Income
$ -11.90M$ -5.80M$ -6.66M$ -7.27M$ -4.03M
Per Share Metrics
Basic EPS
$ -9.90$ -7.05$ -15.15$ -18.60$ -13.80
Diluted EPS
$ -9.90$ -7.05$ -15.15$ -18.60$ -13.80
Weighted Average Shares Outstanding
 1.20M 825.60K 440.94K 392.35K 292.76K
Weighted Average Shares Outstanding (Diluted)
 1.20M 825.60K 440.94K 392.35K 292.76K
Currency in USD

Lexaria Bioscience Earnings and Revenue History